STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
- Conditions
- COVID-19Virus DiseasesCorona Virus Infection
- Interventions
- Drug: Sodium Thiosulfate 25% Solution for Injection
- First Posted Date
- 2022-03-14
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 30
- Registration Number
- NCT05277285
- Locations
- 🇬🇷
General Hospitan of Athens KAT 2nd Department of ICU, Athens, Kifisia, Greece
Personalized Immunotherapy in Sepsis
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 280
- Registration Number
- NCT04990232
- Locations
- 🇮🇹
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
🇩🇪Intensive Care Unit, Jena University Hospital, Jena, Germany
🇬🇷2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece
Addressing Personalized Needs in Clostridioides Difficile Infection
- Conditions
- Clostridioides Difficile Infection
- Interventions
- Diagnostic Test: Microbiome analysis
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 153
- Registration Number
- NCT04725123
- Locations
- 🇬🇷
4th Department of Internal Medicine, ATTIKON University General Hospital, Athens, Greece
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
- Conditions
- MortalitySIRSCommunity-acquired PneumoniaInflammatory ResponseBiomarkersSepsis
- Interventions
- Drug: Tablets
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 278
- Registration Number
- NCT04724044
- Locations
- 🇬🇷
Department of Internal Medicine, Larissa University General Hospital, Larissa, Greece
🇬🇷4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece
🇬🇷1st Department of Internal Medicine, Konstantopouleio-Patission General Hospital, Athens, Greece
suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 606
- Registration Number
- NCT04680949
- Locations
- 🇬🇷
1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens, Greece
🇬🇷1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece
🇬🇷3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens, Greece
Bacillus Calmette-guérin Vaccination to Prevent COVID-19
- Conditions
- COVID-19Corona Virus InfectionCoronary Heart DiseaseChronic Obstructive Pulmonary DiseaseVirus Diseases
- Interventions
- Biological: PlaceboBiological: BCG vaccine
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 301
- Registration Number
- NCT04414267
- Locations
- 🇬🇷
Department of Therapeutics, Alexandra General Hospital, Athens, Greece
🇬🇷Department of Internal Medicine, Patras University Hospital, Patras, Greece
🇬🇷3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
- Conditions
- COVID-19Virus DiseasesCorona Virus Infection
- Interventions
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 90
- Registration Number
- NCT04398004
- Locations
- 🇬🇷
2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece
🇬🇷1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece
🇬🇷COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
- Conditions
- Corona Virus InfectionCOVID-19Virus DiseasesLower Respiratory Tract Infection Viral
- Interventions
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 1000
- Registration Number
- NCT04357366
- Locations
- 🇬🇷
Department of Internal Medicine, University General Hospital of Larissa, Larissa, Greece
🇬🇷2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus, Greece
🇬🇷COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
- Conditions
- COVID-19Virus DiseasesMacrophage Activation SyndromeCorona Virus Infection
- Interventions
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2021-01-11
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 102
- Registration Number
- NCT04339712
- Locations
- 🇬🇷
Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece
🇬🇷Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece
🇬🇷Intensive Care Unit, "Latsio", Thriasio Elefsis General Hospital, ElefsÃna, Greece
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Hellenic Institute for the Study of Sepsis
- Target Recruit Count
- 44
- Registration Number
- NCT04177303
- Locations
- 🇬🇷
Diabetes Center, 1st Internal Medicine Department, AHEPA University General Hospital of Thessaloniki, ThessalonÃki, Thessaloniki, Greece